A 2025 Kinsey Institute survey found more than half of users saw sex life changes, split both ways. Doctors quoted say solid causal evidence is still missing.
Recap by typeshit. Full story at Men's Health.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
STAT
Some telehealth companies now market branded and compounded GLP-1s for alcohol use disorder. Experts quoted by STAT worry about fragmented care for an unproven use.
Healio
Biykem Bozkurt told the Cardiometabolic Health Congress that semaglutide and tirzepatide improve weight, exercise capacity and quality of life in obese HFpEF patients.
Loading…